Zhejiang Xianju Pharmaceutical Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Zhejiang Xianju Pharmaceutical Co.,Ltd.

52 YRS

Zhejiang, China

CNY 989.2 Million

186480 m²

Over 1000 people

Main Products: Medroxyprogesterone Acetate / Cyproterone Acetate / Estradiol Hemihydrate / 17α-Ethynylestradiol / Megestrol Acetate / Norethisterone / Prednisolone / Progesterone / Rocuronium Bromide / Testosterone Enanthate / Testosterone Undecanoate / Vecuronium Bromide

Zhejiang, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturer

Total Employees

1000+ People

Plant Size

280 Acres

Production Experience

52+ Years

Registered Capital

CNY 989.2 Million

MAIN
PRODUCTS

1/3

Medroxyprogesterone Acetate

CAS: 71-58-9

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

1/3

Cyproterone Acetate

CAS: 427-51-0

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

1/3

Estradiol Hemihydrate

CAS: 35380-71-3

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

ABOUT US

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co., Ltd. (Stock Code: 002332), formerly known as Xianju pharmaceutical factory, was founded in 1972. The company implements the corporate mission of "your health and happiness, my sincerity and service". With the development vision of "becoming the top 10 steroid drug suppliers in the world and an enterprise welcomed by customers and employees", the company focuses on the field of steroid hormones. The total share capital of the company is 989204866 yuan, with more than 3600 employees. The company is a key high-tech enterprise of the national torch plan, with Zhejiang steroidal drug engineering technology research center and national postdoctoral workstation. Ranked 67th in the list of top 100 enterprises in China's pharmaceutical industry in 2020. The company's products are unique and adhere to the integrated business model of API and preparation. Its main business is the development, production and sales of steroidal API and preparation. Product R & D focuses on four treatment areas (Gynecology, anesthesiology, respiratory and Dermatology) to build a product group and service group. The company has established long-term cooperative relations with more than 20 domestic famous scientific research institutes (schools) such as Shanghai Institute of organic Sciences of the Chinese Academy of Sciences, Zhejiang University and China Pharmaceutical University to attract senior scientific research talents, and gradually integrate with international new drug development. The company has initially formed a technical architecture system with foreign high-end R & D institutions as the source, Hangzhou and Xianju research institutes as the digestion and reception, and Xianju base as the implementation and implementation. The company has 20 wholly-owned and holding subsidiaries such as Taizhou Xianju Pharmaceutical Co., Ltd. There are three core manufacturing platforms in China: Xianju Yangfu API production area, Xianju Yangfu preparation production area and Linhai South Sichuan production area. In foreign countries, newchem, an Italian subsidiary, has two standardized API factories. Xianju pharmaceutical advocates real culture, win-win culture and innovative culture, and adheres to the enterprise core values of "integrity, hard work, openness, learning, responsibility and win-win". The company adheres to the strategic concept of achieving win-win in customers, enterprises, employees and society, and advocates the value concept that personal value is reflected in the process of realizing enterprise value and social value. In the future development process, the company will continuously improve the management level of the enterprise, continuously develop high-tech products, give play to the scale effect, promote the high-quality development of the enterprise and contribute to the cause of human health.